866-997-4948(US-Canada Toll Free)

Global and China Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021

Published By :

QYResearch

Published Date : Jun 2016

Category :

Cancer

No. of Pages : 180 Pages

The global Drugs for Treatment of Prostate Cancer market was valued at USD 43.47 Billion in 2015, and is projected to reach USD 52.16 Billion by 2021, at a CAGR of 9.99% between 2016 and 2021. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs

This report studies Drugs for Treatment of Prostate Cancer in Global market, including Triptorelin, Leuprorelin, Flutamide Tablets, Goserelin, Bicalutamide Tablets, Bicalutamide Capsules, Estramustine Phosphate Capsules, Mitoxantrone, Zytiga and Xtandi, focuses on price, sales, revenue of each type in global. This report also focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer in America, Established ROW, Western Europe, Emerging Markets, Russia and China, forecast to 2021, from 2015.And Zytiga took up 51.33% market share in 2015.

On basis of segments by Types, this report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers.

On basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Drugs for Treatment of Prostate Cancer, revenue and market share, for key manufacturers. The main manufacturers as follows: IPSEN, Ferring Pharmaceuticals, Takeda Pharmaceutical Company Limited, Schering-Plough Canada, S.C.SINDAN-PHARMA S.R.L., AstraZeneca, Corden Pharma GmbH, Shanxi Zhendong Pharmaceutical, Pfizer, Johnson, Astellas and so on.

On basis of segments by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer in America, Established ROW, Western Europe, Emerging Markets, Russia and China.

On basis of segments by applications, this report focuses on consumption and growth rate of Drugs for Treatment of Prostate Cancer in major applications.

With 180 pages, 216 charts and eight chapters, to display the market present situation and future, clearly and deeply.

Table of Contents

Global and China Drugs for Treatment of Prostate Cancer Research Report to 2021

1 Drugs for Treatment of Prostate Cancer Overview and Each Type
1.1 Product Overview of Prostate Cancer
1.1.1 Definition and Product Scope of Drugs for Prostate Cancer
1.1.2 Global Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.13 China Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.2 Product Segments and Price of Each Type
1.2.1 Product Type of Key Manufacturers
1.2.2 Price List and of Each Type 2015 to 2016
1.2.3 Market Share and Growth Rate of Each Type
1.2.4 Triptorelin and Specification
1.2.5 Leuprorelin and Specification
1.2.6 Flutamide Tablets and Specification
1.2.7 Goserelin and Specification
1.2.8 Bicalutamide Tablets and Specification
1.2.9 Bicalutamide Capsules and Specification
1.2.10 Estramustine Phosphate Capsules and Specification
1.2.11 Mitoxantrone and Specification
1.2.12 Zytiga and Specification
1.2.13 Xtandi and Specification
1.3 Price List (Interviewed) of Each Type for Manufacturers 2015 and 2016
1.3.1 Price List (Interviewed) of Triptorelin by Manufacturers
1.3.2 Price List (Interviewed) of Leuprorelin by Key Manufacturers
1.3.3 Price List (Interviewed) of Flutamide Tablets by Manufacturers
1.3.4 Price List (Interviewed) of Goserelin by Manufacturers
1.3.5 Price List (Interviewed) of Bicalutamide Tablets by Manufacturers
1.3.6 Price List (Interviewed) of Bicalutamide Capsules by Manufacturers
1.3.7 Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers
1.3.8 Price List (Interviewed) of Mitoxantrone by Manufacturers
1.3.9 Price List (Interviewed) of Zytiga by Manufacturers
1.3.10 Price List (Interviewed) of Xtandi by Manufacturers

2 Competition Analysis by Manufacturers in Global and China
2.1 Global Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2015 to 2016
2.2 Global Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2015 to 2016
2.3 Global Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
2.4 China Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.5 China Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.6 China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016

3 Sales and Revenue Segments of Each Type 2010 to 2015
3.1 Global Sales and Revenue Segments of Each Type 2010 to 2015
3.1.1 Global Sales and Market Share of Each Type 2010 to 2015
3.1.2 Global Sales Growth Rate of Each Type 2015 to 2016
3.1.3 Global Revenue and Market Share of Each Type 2015 to 2016
3.1.4 Global Revenue and Market Share of Each Type 2015 to 2016
3.2 Global Sales and Revenue Segments of Each Type 2015 to 2016
3.2.1 Global Sales and Market Share of Each Type 2015 to 2016
3.2.2 Global Sales Growth Rate of Each Type 2015 to 2016
3.2.3 Global Revenue and Market Share of Each Type 2015 to 2016
3.2.4 Global Revenue and Market Share of Each Type 2015 to 2016

4 Market Segments and Forecast of Drugs for Treatment of Prostate Cancer by Regions
4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021
4.1.1 Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021
4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021
4.2 Production and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021
4.2.1 Production and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021
4.2.2 Production Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021
4.3 US Market Forecast to 2021
4.3.1 US Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021
4.4 Western Europe Market Forecast to 2021
4.4.1 Western Europe Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021
4.5 Emerging Markets Market Forecast to 2021
4.5.1 Emerging Markets Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021
4.6 Established ROW Market Forecast to 2021
4.6.1 Established ROW Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021
4.7 Russia Market Forecast to 2021
4.7.1 Russia Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021
4.8 China Market Forecast to 2021
4.8.1 China Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021

5 Raw Materials and Applications
5.1 Key Raw Materials and Price Analysis for Triptorelin
5.1.1 Key Raw Materials for Triptorelin
5.1.2 Price Forecast of Key Raw Materials for Triptorelin 2016 to 2021
5.2 Key Raw Materials and Price Analysis for Leuprorelin
5.2.1 Key Raw Materials for Leuprorelin
5.2.2 Price Forecast of Key Raw Materials for Leuprorelin 2016 to 2021
5.3 Key Raw Materials and Price Analysis for Flutamide Tablets
5.3.1 Key Raw Materials for Flutamide Tablets
5.3.2 Price Forecast of Key Raw Materials for Flutamide Tablets 2016 to 2021
5.4 Key Raw Materials and Price Analysis for Goserelin
5.4.1 Key Raw Materials for Goserelin
5.4.2 Price Forecast of Key Raw Materials for Goserelin 2016 to 2021
5.5 Key Raw Materials and Price Analysis for Bicalutamide Tablets
5.5.1 Key Raw Materials for Bicalutamide Tablets
5.5.2 Price Forecast of Key Raw Materials for Bicalutamide Tablets 2016 to 2021
5.6 Key Raw Materials and Price Analysis for Bicalutamide Capsules
5.6.1 Key Raw Materials for Bicalutamide Capsules
5.6.2 Price Forecast of Key Raw Materials for Bicalutamide Capsules 2016 to 2021
5.7 Key Raw Materials and Price Analysis for Estramustine Phosphate Capsules
5.7.1 Key Raw Materials for Estramustine Phosphate Capsules
5.7.2 Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 2016 to 2021
5.8 Key Raw Materials and Price Analysis for Mitoxantrone
5.8.1 Key Raw Materials for Mitoxantrone
5.8.2 Price Forecast of Key Raw Materials for Mitoxantrone 2016 to 2021
5.9 Key Raw Materials and Price Analysis for Zytiga
5.9.1 Key Raw Materials for Zytiga
5.9.2 Price Forecast of Key Raw Materials for Zytiga 2016 to 2021
5.10 Key Raw Materials and Price Analysis for Xtandi
5.10.1 Key Raw Materials for Xtandi
5.10.2 Price Forecast of Key Raw Materials for Xtandi 2016 to 2021
5.11 Applications of Triptorelin
5.12 Applications of Leuprorelin
5.13 Applications of Flutamide Tablets
5.14 Applications of Goserelin
5.15 Applications of Bicalutamide Tablets
5.16 Applications of Bicalutamide Capsules
5.17 Applications of Estramustine Phosphate Capsules
5.18 Applications of Mitoxantrone
5.19 Applications of Zytiga
5.20 Applications of Xtandi

6 Key Manufacturers Analysis of Drugs for Treatment of Prostate Cancer
6.1 IPSEN
6.1.1 IPSEN Basic Information
6.2.2 Triptorelin (Specification and Price)
6.2.3 Sales Value, Gross Margin 2011-2016
6.1.4 Interviewee, Name and Contact
6.2 Ferring Pharmaceuticals
6.2.1 Company Basic Information
6.2.2 Triptorelin (Specification and Price)
6.2.3 Sales Value, Gross Margin 2011-2016
6.2.4 Interviewee, Name and Contact
6.3 Chengdu Tiantaishan pharmaceutical
6.3.1 Company Basic Information
6.3.2 Triptorelin (Specification and Price)
6.3.3 Sales Value, Gross Margin 2011-2016
6.3.4 Interviewee, Name and Contact
6.4 GeneScience Pharmaceuticals
6.4.1 Company Basic Information
6.4.2 Triptorelin (Specification and Price)
6.4.3 Sales Value, Gross Margin 2011-2016
6.4.4 Interviewee, Name and Contact
6.5 Takeda Pharmaceutical Company Limited
6.5.1 Company Basic Information
6.5.2 Leuprorelin (Specification and Price)
6.5.3 Sales Value, Gross Margin 2011-2016
6.5.4 Interviewee, Name and Contact
6.6 Beijing Biote Pharmaceutical
6.6.1 Company Basic Information
6.6.2 Leuprorelin (Specification and Price)
6.6.3 Sales Value, Gross Margin 2011-2016
6.6.4 Interviewee, Name and Contact
6.7 Livzon Pharmaceutical Group
6.7.1 Company Basic Information
6.7.2 Leuprorelin (Specification and Price)
6.7.3 Sales Value, Gross Margin 2011-2016
6.7.4 Interviewee, Name and Contact
6.8 Schering-Plough Canada
6.8.1 Company Basic Information
6.8.2 Flutamide Tablets (Specification and Price)
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.4 Interviewee, Name and Contact
6.9 JiangSu TASLY DI YI Pharmaceutical
6.9.1 Company Basic Information
6.9.2 Flutamide Tablets (Specification and Price)
6.9.3 Sales Value, Gross Margin 2011-2016
6.9.4 Interviewee, Name and Contact
6.10 Shanghai Fudan Fuhua Pharmaceutical
6.10.1 Company Basic Information
6.10.2 Flutamide Tablets (Specification and Price)
6.10.3 Sales Value, Gross Margin 2011-2016
6.10.4 Interviewee, Name and Contact
6.11 S.C.SINDAN-PHARMA S.R.L.
6.11.1 Company Basic Information
6.11.2 Flutamide Tablets (Specification and Price)
6.11.3 Sales Value, Gross Margin 2011-2016
6.11.4 Interviewee, Name and Contact
6.12 AstraZeneca
6.12.1 Company Basic Information
6.12.2 Goserelin (Specification and Price)
6.12.3 Sales Value, Gross Margin 2011-2016
6.12.4 Interviewee, Name and Contact
6.13 Corden Pharma GmbH
6.13.1 Company Basic Information
6.13.2 Bicalutamide Tablets (Specification and Price)
6.13.3 Sales Value, Gross Margin 2011-2016
6.13.4 Interviewee, Name and Contact
6.14 Shanghai Zhaohui Pharmaceutical
6.14.1 Company Basic Information
6.14.2 Bicalutamide Tablets (Specification and Price)
6.14.3 Sales Value, Gross Margin 2011-2016
6.14.4 Interviewee, Name and Contact
6.15 HISUN Pharmaceutical
6.15.1 Company Basic Information
6.15.2 Bicalutamide Tablets (Specification and Price)
6.15.3 Sales Value, Gross Margin 2011-2016
6.15.4 Interviewee, Name and Contact
6.16 Shanxi Zhendong Pharmaceutical
6.16.1 Company Basic Information
6.16.2 Bicalutamide Capsules (Specification and Price)
6.16.3 Sales Value, Gross Margin 2011-2016
6.16.4 Interviewee, Name and Contact
6.17 Pfizer
6.17.1 Company Basic Information
6.17.2 Estramustine Phosphate Capsules (Specification and Price)
6.17.3 Sales Value, Gross Margin 2011-2016
6.17.4 Interviewee, Name and Contact
6.18 Sichuan sunnyhope pharmaceutical
6.18.1 Company Basic Information
6.18.2 Mitoxantrone (Specification and Price)
6.18.3 Sales Value, Gross Margin 2011-2016
6.18.4 Interviewee, Name and Contact
6.19 Luoxin Group
6.19.1 Company Basic Information
6.19.2 Mitoxantrone (Specification and Price)
6.19.3 Sales Value, Gross Margin 2011-2016
6.19.4 Interviewee, Name and Contact
6.20 Jiangsu Aosaikang Pharmaceutical
6.20.1 Company Basic Information
6.20.2 Mitoxantrone (Specification and Price)
6.20.3 Sales Value, Gross Margin 2011-2016
6.20.4 Interviewee, Name and Contact
6.21 JIANG SU HENG RUI MEDICINE
6.21.1 Company Basic Information
6.21.2 Mitoxantrone (Specification and Price)
6.21.3 Sales Value, Gross Margin 2011-2016
6.21.4 Interviewee, Name and Contact
6.22 Johnson
6.22.1 Company Basic Information
6.22.2 Zytiga (Specification and Price)
6.22.3 Sales Value, Gross Margin 2011-2016
6.22.4 Interviewee, Name and Contact
6.23 Astellas
6.23.1 Company Basic Information
6.23.2 Xtandi (Specification and Price)
6.23.3 Sales Value, Gross Margin 2011-2016
6.23.4 Interviewee, Name and Contact

7 Technology Development Trend
7.1 Manufacturing Process of Drugs for Treatment of Prostate Cancer
7.2 Analysis of Manufacturing Process
7.3 Development Trend

8 Research Findings and Conclusion

List of Table

Figure Picture of Drugs for Prostate Cancer14
Figure Global Market Size (Value) of Drugs for Prostate Cancer 2016-202114
Figure Global Market Size (Volume) of Drugs for Prostate Cancer 2016-202114
Figure China Market Size (Value) of Drugs for Prostate Cancer 2016-202114
Figure China Market Size (Volume) of Drugs for Prostate Cancer 2016-202115
Table Product Type of Key Manufacturers15
Table Price List and Forecast of Each Type15
Table Market Share of Each Type15
Figure Growth Rate of Each Type 2015 to 201616
Figure Picture of Triptorelin16
Table Specification of Triptorelin16
Figure Picture of Leuprorelin16
Table Specification of Leuprorelin17
Figure Picture of Flutamide Tablets17
Table Specification of Flutamide Tablets17
Figure Picture of Goserelin17
Table Specification of Goserelin17
Figure Picture of Bicalutamide Tablets17
Table Specification of Bicalutamide Tablets17
Figure Picture of Type Bicalutamide Capsules17
Table Specification of Type Bicalutamide Capsules18
Figure Picture of Estramustine Phosphate Capsules18
Table Specification of Estramustine Phosphate Capsules18
Figure Picture of Mitoxantrone18
Table Specification of Mitoxantrone18
Figure Picture of Zytiga18
Table Specification of Zytiga18
Figure Picture of Xtandi19
Table Specification of Xtandi19
Table Price List (Interviewed) of Triptorelin by Manufacturers 2015 and 201619
Table Price List (Interviewed) of Leuprorelin by Manufacturers 2015 and 201620
Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 201620
Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 201621
Table Price List (Interviewed) of Bicalutamide Tablets by Manufacturers 2015 and 201621
Table Price List (Interviewed) of Bicalutamide Capsules by Manufacturers 2015 and 201622
Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 201622
Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 201623
Table Price List (Interviewed) of Zytiga Phosphate Capsules by Manufacturers 2015 and 201623
Table Price List (Interviewed) of Xtandi Phosphate Capsules by Manufacturers 2015 and 201624
Table Global Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2015 to 201625
Table Global Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2015 to 201625
Table Global Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2015 to 201626
Table Global Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2015 to 201626
Table Global Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 201627
Table China Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 201528
Table China Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 201528
Table China Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 201529
Table China Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 201529
Table China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 201630
Table Global Sales of Each Type 2010 to 201531
Table Global Sales Market Share of Each Type 2010 to 201531
Table Global Sales Growth Rate of Each Type 2015 to 201631
Table Global Revenue of Each Type 2015 to 201632
Table Global Revenue Market Share of Each Type 2015 to 201632
Table Global Revenue of Each Type 2015 to 201632
Table Global Revenue Market Share of Each Type 2015 to 201633
Table China Sales of Each Type 2015 to 201633
Table China Sales Market Share of Each Type 2015 to 201633
Table Global Sales Growth Rate of Each Type 2015 to 201633
Table China Revenue of Each Type 2015 to 201634
Table China Revenue Market Share of Each Type 2015 to 201634
Table China Revenue of Each Type 2015 to 201634
Table China Revenue Market Share of Each Type 2015 to 201635
Table Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-202136
Figure Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 202137
Table North America Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2015 to 202037
Table Europe Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2015 to 202038
Table Japan Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 202138
Table India Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 202139
Table Southeast Asia Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 202139
Table China Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 202140
Table Key Raw Materials for Triptorelin41
Table Price Forecast of Key Raw Materials for Triptorelin41
Table Key Raw Materials for Leuprorelin42
Table Price Forecast of Key Raw Materials for Leuprorelin42
Table Key Raw Materials for Flutamide Tablets42
Table Price Forecast of Key Raw Materials for Flutamide Tablets43
Table Key Raw Materials for Goserelin43
Table Price Forecast of Key Raw Materials for Goserelin43
Table Key Raw Materials for Bicalutamide Tablets44
Table Price Forecast of Key Raw Materials for Bicalutamide Tablets44
Table Key Raw Materials for Bicalutamide Capsules45
Table Price Forecast of Key Raw Materials for Bicalutamide Capsules45
Table Key Raw Materials for Estramustine Phosphate Capsules45
Table Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules46
Table Key Raw Materials for Mitoxantrone46
Table Price Forecast of Key Raw Materials for Mitoxantrone47
Table Key Raw Materials for Zytiga47
Table Price Forecast of Key Raw Materials for Zytiga47
Table Key Raw Materials for Xtandi48
Table Price Forecast of Key Raw Materials for Zytiga48
Table Applications of Triptorelin48
Table Applications of Leuprorelin49
Table Applications of Flutamide Tablets49
Table Applications of Goserelin49
Table Applications of Bicalutamide Tablets49
Table Applications of Bicalutamide Capsules50
Table Applications of Estramustine Phosphate Capsules50
Table Applications of Mitoxantrone50
Table Applications of Zytiga51
Table Applications of Xtandi51
Table IPSEN Basic Information List52
Table Specification, Price, Sales Value and Market Share of IPSEN52
Table Sales Value, Gross Margin and Growth rate of IPSEN52
Figure Product Sales Value, Growth rate of IPSEN53
Table Ferring Pharmaceuticals Basic Information List53
Table Specification, Price, Sales Value and Market Share of Ferring Pharmaceuticals53
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals54
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals54
Table Chengdu Tiantaishan pharmaceutical Basic Information List54
Table Specification, Price, Sales Value and Market Share of Chengdu Tiantaishan pharmaceutical55
Table Sales Value, Gross Margin and Growth rate of Chengdu Tiantaishan pharmaceutical55
Figure Product Sales Value, Growth rate of Chengdu Tiantaishan pharmaceutical55
Table GeneScience Pharmaceuticals Basic Information List55
Table Specification, Price, Sales Value and Market Share of GeneScience Pharmaceuticals56
Table Sales Value, Gross Margin and Growth rate of GeneScience Pharmaceuticals56
Figure Product Sales Value, Growth rate of GeneScience Pharmaceuticals56
Table Takeda Pharmaceutical Company Limited Basic Information List57
Table Specification, Price, Sales Value and Market Share of Takeda Pharmaceutical Company Limited57
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited57
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited58
Table Beijing Biote Pharmaceutical Basic Information List58
Table Specification, Price, Sales Value and Market Share of Beijing Biote Pharmaceutical58
Table Sales Value, Gross Margin and Growth rate of Beijing Biote Pharmaceutical59
Figure Product Sales Value, Growth rate of Beijing Biote Pharmaceutical59
Table Livzon Pharmaceutical Group Basic Information List59
Table Specification, Price, Sales Value and Market Share of Livzon Pharmaceutical Group60
Table Sales Value, Gross Margin and Growth rate of Livzon Pharmaceutical Group60
Figure Product Sales Value, Growth rate of Livzon Pharmaceutical Group60
Table Schering-Plough Canada Basic Information List60
Table Specification, Price, Sales Value and Market Share of Schering-Plough Canada61
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada61
Figure Product Sales Value, Growth rate of Schering-Plough Canada61
Table JiangSu TASLY DI YI Pharmaceutical Basic Information List61
Table Specification, Price, Sales Value and Market Share of JiangSu TASLY DI YI Pharmaceutical62
Table Sales Value, Gross Margin and Growth rate of JiangSu TASLY DI YI Pharmaceutical62
Figure Product Sales Value, Growth rate of JiangSu TASLY DI YI Pharmaceutical62
Table Shanghai Fudan Fuhua Pharmaceutical Basic Information List63
Table Specification, Price, Sales Value and Market Share of Shanghai Fudan Fuhua Pharmaceutical63
Table Sales Value, Gross Margin and Growth rate of Shanghai Fudan Fuhua Pharmaceutical63
Figure Product Sales Value, Growth rate of Shanghai Fudan Fuhua Pharmaceutical64
Table S.C.SINDAN-PHARMA S.R.L. Basic Information List64
Table Specification, Price, Sales Value and Market Share of S.C.SINDAN-PHARMA S.R.L.64
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L.64
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L.65
Table AstraZeneca Basic Information List65
Table Specification, Price, Sales Value and Market Share of Pfizer65
Table Sales Value, Gross Margin and Growth rate of AstraZeneca66
Figure Product Sales Value, Growth rate of AstraZeneca66
Table Corden Pharma GmbH Basic Information List66
Table Specification, Price, Sales Value and Market Share of Corden Pharma GmbH67
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH67
Figure Product Sales Value, Growth rate of Corden Pharma GmbH67
Table Shanghai Zhaohui Pharmaceutical Basic Information List67
Table Specification, Price, Sales Value and Market Share of Shanghai Zhaohui Pharmaceutical68
Table Sales Value, Gross Margin and Growth rate of Shanghai Zhaohui Pharmaceutical68
Figure Product Sales Value, Growth rate of Shanghai Zhaohui Pharmaceutical68
Table HISUN Pharmaceutical Basic Information List69
Table Specification, Price, Sales Value and Market Share of HISUN Pharmaceutical69
Table Sales Value, Gross Margin and Growth rate of HISUN Pharmaceutical69
Figure Product Sales Value (M USD), Growth rate of HISUN Pharmaceutical70
Table Shanxi Zhendong Pharmaceutical Basic Information List70
Table Specification, Price, Sales Value and Market Share of Shanxi Zhendong Pharmaceutical70
Table Sales Value, Gross Margin and Growth rate of Shanxi Zhendong Pharmaceutical70
Figure Product Sales Value, Growth rate of Shanxi Zhendong Pharmaceutical71
Table Pfizer Basic Information List71
Table Specification, Price, Sales Value and Market Share of Pfizer71
Table Sales Value, Gross Margin and Growth rate of Pfizer72
Figure Product Sales Value, Growth rate of Pfizer72
Table Sichuan sunnyhope pharmaceutical Basic Information List72
Table Specification, Price, Sales Value and Market Share of Sichuan sunnyhope pharmaceutical73
Table Sales Value, Gross Margin and Growth rate of Sichuan sunnyhope pharmaceutical73
Figure Product Sales Value, Growth rate of Sichuan sunnyhope pharmaceutical73
Table Luoxin Group Basic Information List73
Table Specification, Price, Sales Value and Market Share of Luoxin Group74
Table Sales Value, Gross Margin and Growth rate of Luoxin Group74
Figure Product Sales Value, Growth rate of Luoxin Group74
Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List75
Table Specification, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical75
Table Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical75
Figure Product Sales Value, Growth rate of Jiangsu Aosaikang Pharmaceutical76
Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List76
Table Specification, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE76
Table Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE77
Figure Product Sales Value, Growth rate of JIANG SU HENG RUI MEDICINE77
Table Johnson Basic Information List77
Table Specification, Price, Sales Value and Market Share of Johnson78
Table Sales Value, Gross Margin and Growth rate of Johnson78
Figure Product Sales Value, Growth rate of Johnson78
Table Astellas Basic Information List78
Table Specification, Price, Sales Value and Market Share of Astellas79
Table Sales Value, Gross Margin and Growth rate of Astellas79
Figure Product Sales Value, Growth rate of Astellas79
 

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *